Beijing Tsinghua Chang Gung Hospital
🇨🇳China
A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma
Early Phase 1
Not yet recruiting
- Conditions
- Recurrent Glioblastoma
- Interventions
- Drug: Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T cell injection
- First Posted Date
- 2023-04-06
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 22
- Registration Number
- NCT05802693
APP-based Precise Management System of Chronic Intractable Pain
Not Applicable
Recruiting
- Conditions
- Pain, IntractablePain, Chronic
- Interventions
- Other: Precise management
- First Posted Date
- 2023-03-09
- Last Posted Date
- 2023-03-09
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT05761392
- Locations
- 🇨🇳
Beijing Tsinghua Chang Gung Hospital, Beijing, China
Development of a Prediction Model for Intraoperative Blood Pressure Variability
Completed
- Conditions
- Blood Pressure Immeasurable
- Interventions
- Other: No intervention
- First Posted Date
- 2023-01-26
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 47520
- Registration Number
- NCT05698433
- Locations
- 🇨🇳
Zhifeng Gao, Beijing, Beijing, China
Neoadjuvant of Tislelizumab Combined With Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLC
Phase 2
Recruiting
- Conditions
- NSCLC, Stage III
- Interventions
- First Posted Date
- 2022-11-10
- Last Posted Date
- 2023-12-29
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT05611879
- Locations
- 🇨🇳
Beijing Tsinghua Chang Gung Hospital, Beijing, Beijing, China
Efficacy and Safety of Coblopasvir Hydrochloride Capsules Combined With Sofosbuvir Tablets for the Treatment of Chronic HCV Infection: A Prospective, Multi-center Real-world Study.
Not yet recruiting
- Conditions
- Hepatitis C Infection
- First Posted Date
- 2022-11-01
- Last Posted Date
- 2022-11-01
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 450
- Registration Number
- NCT05601518
- Locations
- 🇨🇳
Bejing Tsinghua Changgung Hospital, Beijing, Bejing, China
Donafenib Combined With Hepatic Artery Chemoembolization for Perioperative Treatment of Liver Transplantation
- First Posted Date
- 2022-10-13
- Last Posted Date
- 2023-07-13
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT05576909
- Locations
- 🇨🇳
Beijing Tsinghua Changgung Hospital, Beijing, China
The Association of Marital Status With Kidney Cancer Surgery Morbidity
Completed
- Conditions
- Surgery-ComplicationsCohort StudiesMarriageKidney Neoplasms
- First Posted Date
- 2022-09-02
- Last Posted Date
- 2022-09-06
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 106752
- Registration Number
- NCT05526599
Carotid Artery Stent Implantation in the Treatment of Vulnerable Plaque
Recruiting
- Conditions
- Stent EmbolisationCarotid Artery PlaqueCarotid Stenosis
- Interventions
- Procedure: carotid artery stenting
- First Posted Date
- 2022-09-01
- Last Posted Date
- 2022-09-01
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT05524207
- Locations
- 🇨🇳
Beijing Tsinghua Chang Gung Hospital, Beijing, China
Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
- Conditions
- Fatty Liver Disease
- Interventions
- Diagnostic Test: Fibrotouch
- First Posted Date
- 2022-06-16
- Last Posted Date
- 2022-06-16
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT05421572
- Locations
- 🇨🇳
Bejing Tsinghua Chang Gung Hospital, Beijing, Bejing, China
Effect of PD-1 /PD-L1 Inhibitor Therapy Before Liver Transplantation on Acute Rejection After Liver Transplantation in Patients With Hepatocellular Carcinoma
- Conditions
- Acute RejectionHepatocellular Carcinoma
- First Posted Date
- 2022-06-09
- Last Posted Date
- 2022-06-09
- Lead Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT05411926
- Locations
- 🇨🇳
Beijing Tsinghua Changgung Hospital, Beijing, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath